Glaxo Says Its Covid-19 Antibody Drug Is Likely Effective Against Omicron – The Wall Street Journal

Early laboratory studies suggest that a Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. is effective against the Omicron variant, the companies said, setting i… [+569 chars]